Lumos Pharma Inc Shares Close in on 52-Week Low - Market Mover
The shares closed 1.3% above its 52-week low of $6.80, with trading volume lower than its 30 day average
Jan 11, 2022 by Kwhen Finance Editors
Lumos Pharma Inc (LUMO) shares closed today at 1.3% above its 52 week low of $6.80, giving the company a market cap of $59M. The stock is currently up 2.0% year-to-date, down 68.1% over the past 12 months, and down 46.1% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%.
Trading Activity
- Trading volume this week was 63.7% lower than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.7.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Lumos Pharma Inc | -2.5 | 2.0 | -68.1 | -69.3 | 3.8 |
| Dow Jones Industrial Average | -0.4 | -0.3 | 18.5 | -2.3 | 22.9 |
| S&P 500 Index | -0.1 | -1.9 | 23.9 | -3.6 | 27.3 |
| Health Care | 0.9 | -5.2 | 13.2 | -6.3 | 20.4 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date beats the peer average by 9.2%
- The company's stock price performance over the past 12 months lags the peer average by 384.1%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Lumos Pharma Inc | LUMO | 0 | 2.0 | -68.1 | -69.3 | 3.8 |
| Peer Avg | N/A | 4.6 | 1.9 | -14.1 | -21.2 | 14.6 |
| National Research Corp | NRC | 28.8 | -1.8 | -8.9 | -26.3 | 4.2 |
| Nymox Pharmaceutical Corp | NYMX | -10.4 | 9.2 | -47.4 | -58.6 | 54.3 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: